Addiction News

New data show that rapid initiation with once-monthly Sublocade significantly improved treatment retention vs. standard initiation among patients with opioid use disorder, according to a press release.

The FDA has cleared an investigational new drug application for the RespiRx Nicotine Inhaler (QN-01), an inhaled nicotine replacement therapy, according to a press release.

Patients with alcohol use disorder who used GLP-1 agonists to treat obesity or type 2 diabetes had a decreased risk for hospitalization due to alcohol use disorder, according to a study published in JAMA Psychology.

In this episode, guest Cammie Wolf Rice discusses the opioid crisis, how it impacted her life and family and her foundation’s mission to combating the epidemic and spreading awareness.

SAN ANTONIO — Obesity medications, regardless of class or generation, were associated with reduced alcohol intake among individuals participating in a telehealth weight-loss program, a speaker reported.

Among adult smokers who moved from smoking cigarettes to e-cigarettes exclusively, wheeze resolution went up, but this was not the case if they moved to dual use, according to results published in Nicotine and Tobacco Research.

Fentanyl-involved overdose mortality rates were disproportionately high among American Indian or Alaska Native and Black individuals compared with other racial and ethnic groups, according to a research letter published in JAMA Psychiatry.

ORLANDO — Primary prevention programs for substance abuse should use strategies like those aimed at stress management and navigation of group dynamics, according to a speaker the Lifestyle Medicine Conference.

Current adult smokers with access to a digital pet game within a smoking cessation app had better app engagement and program adherence vs. those without game access, according to results published in Journal of Medical Internet Research.